How can CT complement angiography and intravascular imaging in PCI? Drs. Sandoval and Escaned discuss CT-guided PCI, from preprocedural planning to intraprocedural guidance.
Watch: hubs.ly/Q04Ctppw0
#cardiotwitter #CCTA #TCT2026
Lifetime management is not only a structural heart concept. Igor Gosev, MD, PhD, discusses how HeartMate 3 LVAD therapy and earlier advanced HF referral can preserve future treatment options beyond the next procedure.
hubs.ly/Q04BksvH0 #cardiotwitter
How can CT complement angiography and intravascular imaging in PCI? Drs. Sandoval and Escaned discuss CT-guided PCI, from preprocedural planning to intraprocedural guidance.
Watch: hubs.ly/Q04CtmSm0
#cardiotwitter #CCTA #TCT2026
From Oklahoma City to rural communities, Jim Melton, DO, and Marcus Smith, MD, discuss expanding cardiovascular care beyond the hospital through a hybrid OBL/ASC model, with a focus on access, patient selection, same-day care, and the patient experience.
hubs.ly/Q04zChjx0
Plan your TCT 2026 LBCT schedule! Review CLD's 5-minute overview of selected trials, with clinical context, key endpoints, and presentation times to help you prioritize the results you don't want to miss.
hubs.ly/Q04C8svq0 #cardiotwitter @invasivecardiol
Did you continue — or stop — working invasively in the cath lab during pregnancy? An international study from Hannover Heart Rhythm Center is seeking women to share their experiences in a 15-question survey.
hubs.ly/Q04z_HHs0
#cardiotwitter
How should coronary calcium influence plaque modification during PCI? Jake Rogers and Richard Merschen review IVUS/OCT assessment, atherectomy, IVL, and specialty balloons, with 10 tips for managing calcified lesions.
hubs.ly/Q04CcfJD0 #cardiotwitter @invasivecardiol
Brian K. Jefferson, MD, reviews complex recurrent ISR treated w/ the AGENT™ DCB. An AGENT-treated segment remained patent >3 yrs, while a separate adjacent segment treated w/ POBA 13 mos later restenosed within 6 mos.
hubs.ly/Q04xZXKw0
Procedural choices today can affect tomorrow’s HF options. Igor Gosev, MD, PhD, discusses sternum-preserving HeartMate 3 LVAD implantation and how it may fit into a lifetime advanced HF treatment strategy.
hubs.ly/Q04Bkqdh0 #cardiotwitter
When should an interventional cardiologist think beyond the next coronary procedure? Igor Gosev, MD, PhD, discusses earlier advanced HF referral and HeartMate 3 LVAD therapy as part of a lifetime treatment strategy.
hubs.ly/Q04Bkh5y0 #cardiotwitter










